Skip to content
The Nexus
DossierENTITY

Kevin A. Sabet

Coverage of Kevin A. Sabet in the Nexus archive.

Earliest in view: Apr 19 · 13:00 UTCMost recent: Apr 19 · 13:00 UTC
Co-mentioned in this coverage
Donald Trumpperson1Jay Kopelmanperson1Mission to Live Foundationorganization1Dr. Marc Siegelperson1Healing Breakthroughorganization1Juliana Mercerperson1Foundation for Drug Policy Solutionsorganization1psilocybintopic1MDMAtopic1PTSDtopic1FDAorganization1
Recent coverage
  • HEALTHApr 19 · 13:00 UTCFOX NEWS
    Trump-backed plan could fast-track psychedelic therapies — here’s what to know

    President Trump signed an executive order to fast-track research, funding, and potential FDA approval of psychedelic drugs like psilocybin and MDMA for treating PTSD, depression, and addiction. Supporters, including veterans' advocates and medical analysts, highlight potential benefits for treatment-resistant cases, while critics warn about insufficient safety and efficacy evidence.

Kevin A. Sabet · Dossier · The Nexus